Related Experiment Video
Updated: Jul 31, 2026
10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Diffuse large B-cell lymphoma: insights gained from gene expression profiling.
Izidore S Lossos1, Ronald Levy
1Department of Hematology and Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, Florida 33136, USA.
International Journal of Hematology
|May 31, 2003
Summary
DNA microarrays reveal the complexity of diffuse large B-cell lymphoma (DLBCL), a common non-Hodgkin
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Diffuse large B-cell lymphoma (DLBCL) is the most prevalent form of non-Hodgkin's lymphoma.
- DLBCL is recognized as a highly heterogeneous disease.
- Understanding this heterogeneity is crucial for improving patient outcomes.
Purpose of the Study:
- To review the advancements in understanding DLBCL.
- To highlight the role of gene expression profiling in DLBCL research.
- To discuss the impact of gene expression data on diagnosis, classification, and treatment.
Main Methods:
- Gene expression profiling using DNA microarrays.
- Analysis of global gene expression patterns.
- Literature review of studies applying gene expression profiling to DLBCL.
Main Results:
- Gene expression profiling has elucidated the molecular heterogeneity of DLBCL.
- This approach has provided insights into distinct DLBCL subtypes.
- The data supports improved diagnostic and classification strategies.
Conclusions:
- Gene expression profiling is a powerful tool for dissecting DLBCL complexity.
- Understanding DLBCL heterogeneity through gene expression analysis impacts clinical practice.
- Further application of these techniques promises to refine cancer treatment.
